Schonfeld Strategic Advisors LLC Has $409,000 Stake in Maximus, Inc. (NYSE:MMS)

Schonfeld Strategic Advisors LLC decreased its holdings in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 81.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 5,480 shares of the health services provider's stock after selling 23,741 shares during the period. Schonfeld Strategic Advisors LLC's holdings in Maximus were worth $409,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently modified their holdings of the company. Fort Washington Investment Advisors Inc. OH grew its position in shares of Maximus by 39.1% during the 4th quarter. Fort Washington Investment Advisors Inc. OH now owns 296,476 shares of the health services provider's stock valued at $22,132,000 after buying an additional 83,390 shares during the last quarter. IFP Advisors Inc boosted its stake in Maximus by 62.4% in the fourth quarter. IFP Advisors Inc now owns 786 shares of the health services provider's stock valued at $59,000 after acquiring an additional 302 shares during the period. Mirae Asset Global Investments Co. Ltd. acquired a new position in Maximus in the fourth quarter valued at approximately $1,113,000. Legato Capital Management LLC grew its holdings in shares of Maximus by 33.9% during the fourth quarter. Legato Capital Management LLC now owns 32,134 shares of the health services provider's stock valued at $2,399,000 after purchasing an additional 8,138 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC raised its position in shares of Maximus by 2.4% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 722,172 shares of the health services provider's stock worth $54,748,000 after purchasing an additional 16,772 shares during the period. 97.21% of the stock is owned by institutional investors and hedge funds.

Maximus Stock Performance

Shares of MMS stock traded down $0.47 during trading hours on Friday, reaching $74.86. The stock had a trading volume of 79,145 shares, compared to its average volume of 624,939. The firm has a market capitalization of $4.22 billion, a PE ratio of 16.10 and a beta of 0.61. The firm has a 50-day simple moving average of $68.58 and a 200-day simple moving average of $72.84. Maximus, Inc. has a twelve month low of $63.77 and a twelve month high of $93.97. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.72 and a quick ratio of 1.72.

Maximus (NYSE:MMS - Get Free Report) last issued its quarterly earnings data on Thursday, May 8th. The health services provider reported $2.01 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.37 by $0.64. Maximus had a return on equity of 21.95% and a net margin of 5.28%. The business had revenue of $1.36 billion during the quarter, compared to the consensus estimate of $1.29 billion. During the same period in the previous year, the firm posted $1.57 earnings per share. The business's revenue was up 1.0% on a year-over-year basis. As a group, equities analysts forecast that Maximus, Inc. will post 6.15 earnings per share for the current year.

Maximus Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Saturday, May 31st. Investors of record on Thursday, May 15th will be paid a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.60%. The ex-dividend date is Thursday, May 15th. Maximus's dividend payout ratio is currently 23.86%.

Analysts Set New Price Targets

Separately, StockNews.com lowered Maximus from a "buy" rating to a "hold" rating in a research report on Thursday.

Insider Buying and Selling

In other news, Director Jan Madsen sold 2,439 shares of the company's stock in a transaction on Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total value of $165,144.69. Following the completion of the sale, the director now owns 18,097 shares in the company, valued at $1,225,347.87. This represents a 11.88% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, insider Ilene R. Baylinson sold 14,500 shares of Maximus stock in a transaction that occurred on Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total transaction of $988,030.00. Following the completion of the transaction, the insider now directly owns 2,512 shares in the company, valued at $171,167.68. This represents a 85.23% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.60% of the company's stock.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.